WPC 2019 Program

 

 

Download the Provisional Program & Call For Abstracts

 

 You can continue to scroll down the page to view the sessions being offered.

 

 

 Click here to view the Program-At-A Glance for WPC 2019

What's the difference between plenary, parallel & workshop sessions?

Click here to view the session descriptions.

 


Tuesday, June 4, 2019

Pre-Congress Course I: Fundamentals of PD: The Journey

Pre-Congress Course II: Interdisciplinary and patient centered care for Parkinson's disease

Pre-Congress Course III: Advances in research, science & care

Pre-Congress Course IV: Advocacy course: Activism, awareness, and roles patients play

Pre- Congress Course V: Science, research and care: What members of the pharmaceutical industry should

know about Parkinson's


Wednesday, June 5, 2019

Hot Topics > 8:00 - 9:00 AM

TBD (based on submitted abstracts) sponsored by American Parkinson Disease Association

Award Ceremony > 9:00 - 9:30 AM

Recipient: TBA

Morning Plenary > 9:30 - 11:30 AM

Alpha-synuclein and Parkinson's

Co-Chair: Glenda Halliday (Australia)

Co-Chair: Serge Przedborski (USA)

Talk 1: What is alpha-synuclein - The biology

Speaker: Ronald Melki (France)

Talk 2: The Pathology of alpha-synucleinopathies (brain donation)

Speaker: Shigeo Murayama (Japan)

Talk 3: Patients as living science: The importance of participating in clinical trials

Speaker: Soania Mathur (Canada)

Talk 4: Clinical trials and efficacy of clinical trials targeting alpha-synuclein

Speaker: Jesse Cedarbaum


Lunch > 11:30 AM - 1:30 PM


James Parkinson Special Lecture > 12:15 - 1:15 PM

Pathogenesis and Treatment of Parkinson's Disease

Introduction by: Roger Barker (UK)

Speaker: Yoshikuni Mizuno (Japan)


Parallel Sessions > 1:00 - 3:30 PM

WP1 - Stem Cells in Parkinson's Disease

Co-Chair: Patrik Brundin (USA)

Co-Chair: Hideki Mochizuki (Japan)

Talk 1: Patient-derived cells to study Parkinson's Disease

Speaker: Laurent Roybon (Sweden)

Talk 2: Making authentic midbrain dopamine neurons - The challenges

Speaker: Agnete Kirkeby (Denmark)

Talk 3: Translating a stem cell-derived dopamine cell to a clinical drafting trial for PD

Speaker: Azuka Morizane (Japan)

WP2 - Diagnosis, Mechanisms, and Management of Cognitive Deficits in Parkinson's Disease

Co-Chair: Jennifer Goldman (USA)

Co-Chair: Rebecca Miller (USA)

Talk 1: Cognitive Deficits in Parkinson's disease: Clinical features, diagnosis, and evolution

Speaker: Caroline Williams-Gray (UK)

Talk 2: Neuropathology of cognitive deficits in PD and its insights into therapeutic interventions

Speaker: Tom Montine (USA)

Talk 3: Therapeutic programs for cognitive health in PD - interventions and preventions

Speaker: Atsushi Takeda (Japan)

WP3 - Sleep Disorders

Co-Chair: Anne Louise Lafontaine (Canada)

Co-Chair: Simon Lewis (Australia)

Talk 1: An overview of sleep disorders in Parkinson's disease

Speaker: Isabelle Arnulf (France)

Talk 2: The restorative function of sleep: How sleep clears away protein debris

Speaker: To be announced

Talk 3: Tips and tricks to managing sleep disorders in Parkinson's

Speaker: Aleksander Videnovic (USA)

Japanese Track

To Be Announced


Workshops > 1:00 - 3:30 PM

WW1 - Selective Neuronal Vulnerability:
What we can and cannot learn about pathogenesis of PD using models

Co-Chair: Etienne Hirsch (France)

Co-Chair: Jeffrey Kordower (USA)

Talk 1: The role of development in laying the foundation for the selective neuronal vulnerability of PD

Speaker: Ernest Arenas (Sweden)

Talk 2: The role of cellular thresholds in driving selective neuronal vulnerability of PD

Speaker: David Sulzer (USA)

Talk 3: The role of neural circuits in PD

Speaker: Daniele Calligiore (Italy)

WW2 - Wearable Apps for Monitoring PD and its treatment

Co-Chair: Elena Moro (France)

Co-Chair: Sara Riggare (Sweden)

Talk 1: State of the art of wearable devices in Parkinson's disease

Speaker: Joachim Ferreira (Portugal)

Talk 2: Applications of wearable devices in clinical trials

Speaker: Tanya Simuni (USA)

Talk 3: Future direction of wearable and monitoring technologies

Speaker: Walter Maetzler (Germany)

WW3 - Levodopa and Dopamine Agonists:
How to find a balance between the good and the not so good

Co-Chair: Angela Cenci-Nilsson (Sweden)

Co-Chair: Andy McDowell (New Zealand)

Talk 1: The history of levodopa and dopamine agonists - Benefits and myths

Speaker: Stanley Fahn (USA)

Talk 2: Learn how to recognize and manage L-dopa induced dyskinesias

Speaker: Masahiko Tomiyama (Japan)

Talk 3: To learn how to recognize and manage impulse control disorders and dopa-dysregulation syndrome

Speaker: Annette Hand (UK)


Roundtables  > 1:00 - 3:30 PM

WRT 1 - Sponsored by American Parkinson Disease Association

Round Table 1: Coping day to day: Managing the emotions of Parkinson's disease

Lissa Kapust (USA)

Round Table 2: Tips on getting your research published

Elena Becker-Barroso (UK)

Round Table 3: New insights into the function of LRRK2 from a genetic point of view

Matt Farrer (Canada)

Round Table 4: LRRK2, the autophagy-lysosome system and PD

Jie Shen (USA)

Round Table 5: Combined pharmacotherapy and neuromodulation approaches to PD

John Rothwell (USA)

Round Table 6: Effectiveness and reliability of TMS treatment, new methods and future perspectives

Angelo Quartarone (Italy)

Round Table 7: What is alpha-synuclein - The biology

Ronald Melki (France)

Round Table 8: Pathological features of alpha-synucleinopathies

Shigeo Murayama (Japan)

Round Table 9: The importance of participating in clinical trials

Soania Mathur (Canada)

Round Table 10: Approaches to voice training in PD

Host to be announced.

Round Table 11: How PD affects sexuality and Intimacy of PwPD and their care-partners?

Sheila Silver (USA)

Round Table 12: Planet Patient vs Planet Researcher: How do we align instead of collide?

Simon Stott (UK) & to be announced


Coffee Break > 3:00 - 3:30 PM


Parallel Sessions > 3:30 - 5:00 PM

WP4 - LRRK2 and Its Relationship to Endosomal Biology

Co-Chair: Mark Cookson (USA)

Co-Chair: Anthony Schapira (UK)

Talk 1: New insights into the function of LRRK2 from a genetic point of view

Speaker: Matt Farrer (Canada)

Talk 2: LRRK2, the autophagy-lysosome system and PD

Speaker: Jie Shen (USA)

Talk 3: LRRK2 as a therapeutic target

Speaker: Brian Fiske (USA)

WP5 - The Microbiome and Diet in Parkinson's disease

Co-Chair: Marie-Francoise Chesselet (USA)

Co-Chair: Frank Church (USA)

Talk 1: Inflammation, microbiome and PD: what is all the fuss about?

Speaker: Viviane LaBrie (USA)

Talk 2: What is the evidence for, and the relevance of, GIT pathology in PD?

Speaker: Pascal Derkinderen (France)

Talk 3: Is there any evidence that nutrients modify PD?

Speaker: Laurie Mischley (USA)

WP6 - Depression, Anxiety, and Apathy in PD - Part 1

Co-Chair: Shen Yang Lim (Malaysia)

Co-Chair: Julio Angulo (USA)

Talk 1: Understanding apathy: what it is, what it is not and its impact on disease

Speaker: Kathy Dujardin (France)

Talk 2: Anxiety in Parkinson's disease - symptoms, frequency, and neurobiology

Speaker: Roseanne Dobkin (USA)

Talk 3: Understanding depression in Parkinson's disease - Symptoms, frequency, and neurobiology

Speaker: Murat Emre (Turkey)

Japanese Track

To Be Announced


Workshops > 3:30 - 5:00 PM

WW4 - Transcranial magnetic stimulation in Parkinson's disease: from basic to clinical research

Co-Chair: Paolo Calabresi (Italy)

Co-Chair: Stephane Lehericy (France)

Talk 1: Deciphering transcranial magnetic stimulation mechanisms in early and late experimental parkinsonism

Speaker: Veronica Ghilieri (Italy)

Talk 2: Combined pharmacotherapy and neuromodulation approaches to PD

Speaker: John Rothwell (UK)

Talk 3: Effectiveness and reliability of TMS treatment, new methods and future perspectives

Speaker: Angelo Quartarone (Italy)

WW5 - How to distinguish fake from real scientific and clinical advances

Co-Chair: Jonathan Kimmelman (Canada)

Co-Chair: Simon Stott (UK)

Talk 1: How do journals decide what to publish and promote?

Speaker: Elena Becker-Barroso (UK)

Talk 2: How does the media choose stories and sell them?

Speaker: Jon Palfreman

Talk 3: How do you assess all the information that is out there?

Speaker: Benjamin Stecher (Canada)

WW6 - Sexuality and intimacy in Parkinson's for people with Parkinson's and their partners

Co-Chair: Victor McConvey (Australia)

Co-Chair: Lucie Lachance (Canada)

Talk 1: How PD affects sexuality and intimacy of PwP and their care partners? 

Speaker: Sheila Silver (USA)

Talk 2: Medical and non-medical management  of sexual problems in PD

Speaker: Jim Bender (The Netherlands)

Talk 3: How to communicate on sexual issues with my inter-professional team

Speaker: Gila Bronner (Israel)


Roundtables  > 3:30 - 5:00 PM

WRT 2

Round Table 1: Sleep & PD: Tips and tricks

Aleksander Videnovic (USA)

Round Table 2: Therapeutic programs for cognitive health in PD

Atsushi Takeda (Japan)

Round Table 3: Cognitive deficits in Parkinson's disease: Clinical features, diagnosis, and evolution

Caroline Williams-Gray (UK)

Round Table 4: The challenges of making authentic dopamine neurons from stem cells

Agnete Kirkeby (Denmark)

Round Table 5: Translating stem cell therapies to the clinic for trialling 

Azuka Morizane (Japan)

Round Table 6: The role of cellular thresholds in selective neuronal vulnerability in PD

David Sulzer (USA)

Round Table 7: The history of levodopa and dopamine agonists, benefits and myths

Stanley Fahn (USA)

Round Table 8:

Topic and host to be announced 

Round Table 9: Alpha-synuclein and the immune response in PD

Ashley Harms (USA)

Round Table 10: Mechanisms underlying impulsive behaviors and addictions in Parkinson's disease

Christelle Baunez (France)

Round Table 11: Diagnosed with PD . . . Now what?

Andy McDowell (New Zealand)

Round Table 12: Managing dyskinesias

Masahiko Tomiyama (Japan)


Daily > 5:15 - 6:30 PM

WWU - Daily Wrap-Up Panels WPT - Poster Tours

Chair: Patrik Brundin

Panelist 1: Jennifer Goldman (USA)

Panelist 2: Angela Cenci-Nilsson (Sweden)

Panelist 3: Sara Riggare (Sweden)

Panelist 4: Paolo Calabresi (Italy)

Panelist 5: Ryosuke Takahashi (Japan)

Guides:

Poster Tour 1: TBD - Laurent Roybon (Sweden)

Poster Tour 2: TBD - Host to be announced

Poster Tour 3: TBD - Ashley harms (UK)

Poster Tour 4: TBD - Tom Montine (USA)

Poster Tour 5: TBD - Glenda Halliday (Australia)

Poster Tour 6: TBD - Angelo Quartarone (Italy)

Poster Tour 7: Wearable Devices - Tanya Simuni (USA)

Poster Tour 8: TBD - Nicolas Dzamco (Australia)

Poster Tour 9: TBD - Isabelle Arnulf (France)


Thursday, June 6, 2019

Hot Topics > 8:00 - 9:00 AM

TBD (based on submitted abstracts) sponsored by American Parkinson Disease Association

Award Ceremony > 9:00 - 9:30 AM

Recipient: TBA

Morning Plenary > 9:30 - 11:30 AM

Are we moving towards personalized medicine?

Co-Chair: Etienne Hirsch (France)

Co-Chair: Ryosuke Takahashi (Japan)

Talk 1: Heterogeneity of Parkinson's disease

Speaker: Connie Marras (Canada)

Talk 2: How are the genetics of Parkinson's disease influencing treatment development?

Speaker: Anthony Schapira (UK)

Talk 3: New trial approaches to treating Parkinson's disease

Speaker: Oliver Rascol (France)

Talk 4: What's it like to live with a gene for Parkinson's disease?

Speaker: To be announced


Lunch > 11:30 AM - 1:30 PM


Living well with Parkinson's disease: What's your secret?

> 12:15 - 1:15 PM

Chair: Raj Pahwa (USA)

Panelist 1: Allison Smith (USA)

Panelist 2: Yoshiko Okada (Japan)

Panelist 3: Emma Lawton (UK)

Panelist 4: Elisabeth Ildal (Denmark)

Panelist 5: Benjamin Stecher (Canada)


Parallel Sessions > 1:00 - 3:30 PM

TP1 - Basal Ganglia Oscillations and Circuitry in Parkinson's Disease

Co-Chair: Elena Moro (France)

Co-Chair: Barbara Picconi (Italy)

Talk 1: Oscillatory activities in cortico-basal ganglia networks in animal models of PD

Speaker: Atsushi Nambu (Japan)

Talk 2: Optogenetic modulation of basal ganglia activity in Parkinsonian models

Speaker: Stella Papa (USA)

Talk 3: Adaptive brain stimulation for the treatment of PD: Where are we with this?

Speaker: Alberto Priori (Italy)

TP2 - The Major Discoveries in Parkinson's Over the Last 10 Years

Co-Chair: Tim Anderson (New Zealand)

Co-Chair: Walter Maetzler (Germany)

Talk 1: Alpha-synuclein: A story of accumulation and spread

Speaker: Maria Grazia Spillantini (UK)

Talk 2: Preclinical and prodromal PD: Predictive and risk factors

Speaker: Michele Hu (UK)

Talk 3: iPS and PD

Speaker: Jun Takahashi (Japan)

TP3 - End of Life Planning and Care for Parkinsonism

Co-Chair: Julie Carter (USA)

Co-Chair: Anne Louise Lafontaine (Canada)

Talk 1: State of the art of palliative care in Parkinson's disease: A global perspective

Speaker: Victor McConvey (Australia)

Talk 2: Palliative care in your hands: Advance care planning in parkinsonian disorders

Speaker: Roongroj Bhidayasiri (Thailand)

Talk 3: Case studies in palliative care for parkinsonian disorders

Speaker: Barry Snow (New Zealand)

TP4 - Why Do People with Parkinson's Fall and Can Falls be Prevented?

Co-Chair: Laurie King (USA)

Co-Chair: Jillian Carson (Canada)

Talk 1: Can we predict (and therefore minimize) falls

Speaker: Colleen Canning (Australia)

Talk 2: Factors that contribute to falls

Speaker: Anat Mirelman (Israel)

Talk 3: Solutions to minimize falls

Speaker: Lynn Rochester (UK)


Workshops > 1:00 - 3:30 PM

TW1 - The Role of Inflammation and the Immune System in Parkinson's Disease

Co-Chair: David Standaert (USA)

Co-Chair: Caroline Williams-Gray (UK)

Talk 1: Alpha-synuclein and the immune response in PD

Speaker: Ashley Harms (USA)

Talk 2: Enhancing clearance of alpha-synuclein by immune related cells for neuroprotection

Speaker: Nadia Stefanova (Austria)

Talk 3: LRRK2 in the Immune System

Speaker: Nicolas Dzamco (Australia)

TW2 - Pain and Parkinson's Disease

Co-Chair: Jon Stoessl (Canada)

Co-Chair: Karen Raphael (USA)

Talk 1: Pain syndromes occurring in Parkinson's disease: Presentations and assessment

Speaker: Santiago Perez-Lloret (Argentina)

Talk 2: Current understanding of underlying mechanisms of pain syndromes in PD

Speaker: Alfredo Berardelli

Talk 3: Treatment approaches and clinical trials for pain in PD

Speaker: Beom Jeon (South Korea)

TW3 - YOPD: It's Not All About the Symptoms - Other Life Considerations

Co-Chair: Soania Mathur (Canada)

Co-Chair: Heather Kennedy (USA)

Talk 1: Diagnosed with YOPD - Next steps

Speaker: Andy McDowell (New Zealand)

Talk 2: Tips and tricks for maintaining work/life balance

Speaker: Rebecca Miller (USA)

Talk 3: PD is in the house - Impact on children/teens/young adults

Speaker: Elaine Book (Canada)


Roundtables  > 1:00 - 3:30 PM

TRT 1

Round Table 1: Living well with young-onset Parkinson's

Tim Hague (Canada)

Round Table 2: Inflammation, microbiome and PD: What is all the fuss about?

Vivian LaBrie (USA)

Round Table 3: Is there any evidence that nutrients modify PD?

Laurie Mischley (USA)

Round Table 4: LRRK2 as a therapeutic target

Brian Fiske (USA)

Round Table 5: I have Parkinson's and I care about my genetics: You should too

Martin Taylor (UK)

Round Table 6: Gut microbiota: Putting the puzzle together

Filip Scheperjans (Finland)

Round Table 7: Experimental pharmacological treatments for Parkinson's disease

Jeff Conn (USA)

Round Table 8: The challenge of disease classification

Rejko Krüger (Luxembourg)

Round Table 9: What is alpha-synuclein and what goes wrong with it in PD

Jeffery Kordower (USA)

Round Table 10: LRRK2 and Parkinson's

Mark Cookson (USA)

Round Table 11: How do you find a good "druggable" candidate in the lab?

Erwan Bezard (France)

Round Table 12: Stem cell tourism - Why is it dangerous?

Jonathan Kimmelman (Canada)


Coffee Break > 3:00 - 3:30 PM


Parallel Sessions > 3:30 - 5:00 PM

TP5 - The Proteinopathy of Parkinson's Disease and its Role in Pathogenesis

Co-Chair: Serge Przedborski (USA)

Co-Chair: Ronald Melki (France)

Talk 1: Synuclein and its role at the synapse

Speaker: Robert Edwards (USA)

Talk 2: The links between mitochondrial failure and lysosomal dysfunction with alpha-synuclein aggregation

Speaker: Dimitri Krainc (USA)

Talk 3: PINK1, Parkin and the ubiquitin system

Speaker: Noriyuki Matsuda (Japan)

TP6 - Advancing Research, Clinical Trials and Real- World Data

Co-Chair: Simon Lewis (Australia)

Co-Chair: Jasmine Sturr (USA)

Talk 1: Where are we with clinical trials right now in PD?

Speaker: Tom Foltynie (UK)

Talk 2: What is it like to be the patient in a clinical trial? It's not all about the drugs.

Speaker: Richard Windle (UK)

Talk 3: Using real-world data as an alternative to clinical trials

Speaker: Bas Bloem (The Netherlands)

TP7 -Important Non-Motor Symptoms that are Often Overlooked

Co-Chair: Lucie LaChance (Canada)

Co-Chair: Hirohide Takahashi (Japan)

Talk 1: Evaluating and managing sexual dysfunction in PD

Speaker: Sharon Hassin-Baer (Israel)

Talk 2: Urological dysfunction in PD - What is it and what can be done about it?

Speaker: Ryuji Sakakibara (Japan)

Talk 3: Managing orthostatic hypotension in PD

Speaker: Stuart Isaacson (USA)

TP8 - Strategies to Optimize Daily Living in PwP: Physical, Occupational and Speech Therapies

Co-Chair: Lee Dibble (USA)

Co-Chair: Jennifer Cody (USA)

Talk 1: Can we predict (and therefore minimize) falls in PD?

Speaker: Lynn Rochester (UK)

Talk 2: Facial Masking: What are the social implications?

Speaker: Hanneke Kalf (The Netherlands)

Talk 3: Impact of early training to improve vocalization in PD

Speaker: Michelle Troche


Workshops > 3:30 - 5:00 PM

TW4 - Advancing the Pharmacology of Parkinson's disease

Co-Chair: To be announced

Co-Chair: Oliver Rascol (France)

Talk 1: Experimental pharmacological treatments for Parkinson's disease

Speaker: Jeff Conn (USA)

Talk 2: New insights into L-Dopa induced dyskinesias

Speaker: Barbara Picconi (Italy)

Talk 3: Mechanisms underlying impulsive behaviors and addictions in Parkinson's disease

Speaker: Christelle Baunez (France)

TW5 - The Role of Genetics and Genetic Testing in PD

Co-Chair: Susanne Schneider (Germany)

Co- Chair: Martin Taylor (UK)

Talk 1: The role of genetics in increasing our understanding of the pathopysiology of PD

Speaker: John Hardy (UK)

Talk 2: Genetic testing in PD - What is possible and why is it important?

Speaker: Vincenzo Bonifati (The Netherlands)

Talk 3: Ethical and legal aspects of genetic testing in PD

Speaker: To be announced

TW6 - Music & Dance for Parkinson's Disease

Co-Chair: Terry Ellis (USA)

Co-Chair: David Leventhal (USA)

Talk 1: How can dance be helpful in PD?

Speaker: Meg Morris (Australia)

Talk 2: The effects of music on the brain

Speaker: To be announced

Talk 3: Why partnered dance might optimize motor and cognitive rehabilitation in Parkinson's

Speaker: Madeleine Hackney (USA)


Roundtables  > 3:30 - 5:00 PM

TRT 2

Round Table 1: Palliative Care is in your hands

Roongroj Bhidayasiri (Thailand)

Round Table 2: iPS cells and PD - What does this mean in 2019?

Jun Takahashi (Japan)

Round Table 3: Predicting who will get Parkinson's disease

Isabelle Arnulf (France)

Round Table 4: Shining a light on Parkinsons: Optogenetic modulation of basal ganglia activity

Stella Papa (USA)

Round Table 5: Treatment approaches and clinical trials for pain in PD

Beom Jeon (South Korea)

Round Table 6: The heterogeneity of Parkinson's disease - What does it mean and why is it important

Connie Marras (Canada)

Round Table 7: Maintaining balance and optimism when working  and raising children with young onset PD

Rebecca Miller (USA)

Round Table 8: Parkinson's and the gut microbiome

Haydeh Payami (USA)

Round Table 9: Measuring gut function in PD

Kathleen Shannon (USA)

Round Table 10: Is inflammation important in PD?

David Standaert (USA)

Round Table 11: New causative genes for PD

Alexis Brice (France)

Round Table 12: Is there a Parkinson's diet?

Karin Overbeek (The Netherlands)


Daily > 5:15 - 6:30 PM

TWU - Daily Wrap-Up Panels TPT - Poster Tours

Chair: Serge Przedborski (USA)

Panelist 1: Tim Anderson (New Zealand)

Panelist 2: Roger Barker (UK)

Panelist 3: Julie Carter (USA)

Panelist 4: Anthony Schapira (UK)

Panelist 5: To be announced

Guides:

Poster Tour 1: TBD - Malu Tansey (USA)

Poster Tour 2: TBD - Luci LaChance (Canada)

Poster Tour 3: Nutrition & diet -Karin Overbeek (The Netherlands)

Poster Tour 4: Exercise, balance, and falls - Margaret Mak (Hong Kong)

Poster Tour 5: TBD - Anne Louise Lafontaine (Canada)

Poster Tour 6: TBD - Aletta D. Kraneveld (The Netherlands)

Poster Tour 7: TBD - Maria Grazia-Spillantini (UK)

Poster Tour 8: TBD - Susanne Schneider (Germany)

Poster Tour 9: TBD - Hirohide Takahashi (Japan)

Poster Tour 10: TBD - Lucilla Parnetti (Italy)


Friday, June 7, 2019

Hot Topics > 8:00 - 9:00 AM

TBD (based on submitted abstracts) sponsored by American Parkinson Disease Association

Award Ceremony > 9:00 - 9:30 AM

Recipient: TBA

Morning Plenary > 9:30 - 11:30 AM

The peripheral aspects of Parkinson's disease - It is not just a brain disease!

Co-Chair: Hideki Mochizuki (Japan)

Co-Chair: Patrik Brundin (USA)

Talk 1: PD is not just about the brain, trust me

Speaker: Heather Kennedy (USA)

Talk 2: Overview of peripheral (non-brain/CNS) abnormalities in PD

Speaker: Jeffrey Kordower (USA)

Talk 3: Does PD start outside the brain?

Speaker: Per Borghammer (Denmark)

Talk 4: Managing of the peripheral problems in PD

Speaker: Shen Yang Lim (Malaysia)


Lunch > 11:30 AM - 1:30 PM


Special Lecture > 12:15 - 1:15 PM

Cellular Reprogramming - What does it mean for the future of medicine?

Introduction by: Yoshikuni Mizuno (Japan)

Speaker: Shinya Yamanaka (Japan)


Parallel Sessions > 1:00 - 3:30 PM

FP1 - The GI Tract, Microbiome and Parkinson's

Co-Chair: Malu Tansey (USA)

Co-Chair: Pascal Derkinderen (France)

Talk 1: Gut microbiota, 1,013 new pieces in the Parkinson's disease puzzle

Speaker: Filip Scheperjans

Talk 2: Parkinson's disease and Parkinson's disease medications have distinct signatures with respect to the gut microbiome

Speaker: Haydeh Payami (USA)

Talk 3: Measuring GI function in Parkinson's disease

Speaker: Per Borghammer (Denmark)

FP2 - New Therapies and Emerging Therapies in PD

Co-Chair: Kalpana Merchant (USA)

Co-Chair: Raj Pahwa (USA)

Talk 1: Immune therapies for PD

Speaker: Seung Jae Lee (Korea)

Talk 2: New surgery for PD

Speaker: Binit Shah (USA)

Talk 3: Repurposing drugs for PD

Speaker: Michael Schwarzschild (USA)

FP3 - Is There a "Best" Exercise for Parkinson's Disease?

Co-Chair: Joaquim Ferreira (Portugal)

Co-Chair: Laurie King (USA)

Talk 1: Aerobic exercise for PD

Speaker: Terry Ellis (USA)

Talk 2: Strengthening exercise for PD

Speaker: Lee Dibble (USA)

Talk 3: Complex balance training for PD

Speaker: Margaret Mak (Hong Kong)

 

Japanese Track

Workshops > 1:00 - 3:30 PM

FW1 - The Role of Aging in Parkinson's Disease

Co-Chair: Glenda Halliday (Australia)

Co-Chair: Maria Grazia Spillantini (UK)

Talk 1: Aging of the immune system and relevance to brain health and disease

Speaker: Michal Schwartz (Israel)

Talk 2: Aging and proteostasis - Its implications for PD

Speaker: To be announced

Talk 3: Aging mitochondrial function and bioenergetics - What does this mean for PD pathogenesis?

Speaker: To be announced

FW2 - What is the Best Biomarker in Parkinson's Disease

Co-Chair: Michele Hu (UK)

Co-Chair: Jean Burns (USA)

Talk 1: The use of neuroimaging as a biomarker in PD

Speaker: Stephane Lehericy (France)

Talk 2: The current status of "wet" biomarkers (blood, CSF, etc) as a biomarker in PD

Speaker:Lucilla Parnetti (Italy)

Talk 3: Could biopsies from outside the brain help in the diagnosis and tracking of PD?

Speaker: Kathleen Shannon (USA)

FW3 - The Voice and Respiration in PD

Co-Chair: Hanneke Kalf (The Netherlands)

Co-Chair: To be announced

Talk 1: Overview of voice and breathing in Parkinson's disease

Speaker: Michelle Troche (USA)

Talk 2: Approaches to voice training in PD

Speaker: To be announced

Talk 3: Maintenance of intelligibility after voice training in PD

Speaker: Jennifer Cody (USA)


Roundtables  > 1:00 - 3:30 PM

FRT 1

Round Table 1: What is left to be discovered in PD?

Tim Anderson (New Zealand)

Round Table 2: Where are we with clinical trials in PD in 2019?

Tom Foltynie (UK)

Round Table 3: What is it like to be a patient in a clinical trial? It's not all about the drugs

Richard Windle (UK)

Round Table 4: Using real world data as an alternative to clinincal trials

Bas Bloem (The Netherlands)

Round Table 5: Using stem cells and organoids to understand PD pathogenesis

Ernest Arenas (Sweden)

Round Table 6: Pain and PD: Patient reality and what we know

Karen Raphael (USA)

Round Table 7: The role of genetics in better understanding the pathophysiology

John Hardy (UK)

Round Table 8: Insulin resistance, diabetes and Parkinson's disease

Dilan Athauda (UK)

Round Table 9: The links between mitochondrial failure and lysosomal dysfunction and alpha-synuclein aggregation

Dimitri Krainc (USA)

Round Table 10: PINK1, parkin and the ubiquitin system - How do they link to what goes wrong in PD

Noriyuki Matsuda (Japan)

Round Table 11: Medical and non-medical management of sexual problems in PD

Jim Bender (The Netherlands)

Round Table 12: Building a one-stop-shop for Parkinson's: Where to start?

Jillian Carson (Canada)


Coffee Break > 3:00 - 3:30 PM


Parallel Sessions > 3:30 - 5:00 PM

FP4 - Metabolism, Stress, and Parkinson's Disease

Co-Chair: Tom Foltynie (UK)

Co-Chair: Marie-Francoise Chesselet (USA)

Talk 1:The role of mitochondrial dysfunction and energy failure in PD

Speaker: Ted Dawson (USA)

Talk 2:Insulin resistance, diabetes and Parkinson's disease - How do they link together?

Speaker: Dilan Athauda (UK)

Talk 3: Physiological stress and its role in the pathogenesis of PD

Speaker: Stéphane Hunot (France)

FP5 - How do you Take a Therapy from the Lab, to the Clinic, to the Market

Co-Chair: Atsushi Takeda (Japan)

Co-Chair: Stuart Isaacson (USA)

Talk 1: How do you find a good candidate in the lab?

Speaker: Erwan Bezard (France)

Talk 2: How do I conduct lab research to develop a theory for PD: from model systems to clinical trials?

Speaker: Kalpana Merchant (USA)

Talk 3: How to move from a first in human study to a marketable drug?

Speaker: Jesse Cedarbaum (USA)

FP6 - The Ins and Outs of Eating in Parkinson's Disease

Co-Chair: Hanneke Kalf (The Netherlands)

Co-Chair: Laurie Mischley (USA)

Talk 1: How to get food & liquid in despite swallowing problems?

Speaker: Sonoko Nozaki (Japan)

Talk 2: Is there a Parkinson's diet?

Speaker: Karin Overbeek (The Netherlands)

Talk 3: How to keep your GI tract functioning

Speaker: Aletta D. Kraneveld (The Netherlands)

Japanese Track

Workshops > 3:30 - 5:00 PM

FW4 -Neurogenetics in Parkinson's Disease: From Monogeneic Forms of PD to Susceptible Genes for Sporadic Forms of the Disease

Co-Chair: Matt Farrer (Canada)

Co-Chair: Nobutaka Hattori (Japan)

Talk 1: New causative genes for PD

Speaker: Alexis Brice (France)

Talk 2: Next generation sequencing strategies and its role in identifying genetic risk factors for Parkinson's disease

Speaker: Tatsushi Toda (Japan)

Talk 3: The challenge of disease classification in PD - What does it look like and what does it mean?

Speaker: Rejko Krüger (Luxembourg)

FW5 - Stem cells in Parkinson's Disease

Co-Chair: Roger Barker (UK)

Co-Chair: Agnete Kirkeby (Denmark)

Talk 1: Using stem cells and organoids to understand PD pathogenesis

Speaker: Ernest Arenas (Sweden)

Talk 2: Using stem cells to treat PD

Speaker: Jun Takahashi (Japan)

Talk 3: Stem cell tourism - What is it all about?

Speaker: Jonathan Kimmelman (Canada)

FW6 - Depression, Anxiety, and Apathy in PD: How to Best Manage it - Part 2

Co-Chair: Shen Yang Lim (Malaysia)

Co-Chair: Julio Angulo (USA)

Talk 1: Apathy: Is there a treatment?

Speaker: Kathy Dujardin (France)

Talk 2: Anxiety: How best to manage it

Speaker: Roseanne Dobkin (USA)

Talk 3: Depression: How best to treat it

Speaker: To be announced


Roundtables  > 3:30 - 5:00 PM

FRT 2

Round Table 1: Oscillatory activities in cotico-basal gaglia networks in animal models of PD

Atsushi Nambu (Japan)

Round Table 2: Immune therapies for PD

Seung Jae Lee (Korea)

Round Table 3: Repurposing Drugs for PD

Michael Schwarzschild (USA)

Round Table 4: Could biopsies from outside the brain help in the diagnosis and tracking of PD?

Host to be announced

Round Table 5: Aerobic exercise for Parkinson's disease - Useful or not?

Terry Ellis (USA)

Round Table 6: New Insights into L-Dopa induced dyskinesias

Barbara Picconi (Italy)

Round Table 7: Aging of the immune system and its relevance to brain health and PD

Michal Schwartz (Israel)

Round Table 8: Aging of the mitochondria and its contribution to PD pathogenesis

Host to be announced

Round Table 9: A family affair: Well-being for everyone when a diagnosis of PD knocks on the door

Jasmine Sturr (USA)

Round Table 10: Music & dance for Parkinson's disease

Meg Morris (Australia)

Round Table 11: Sexual intimacy and Parkinson's

Gila Bronner (Israel)

Round Table 12: Where are we with DBS?

Elena Moro (France)


Daily > 5:15 - 6:30 PM

FWU - Daily Wrap-Up Panels

Chair: Jon Stoessl (Canada)

Panelist 1: Ted Dawson (USA)

Panelist 2: Joaquim Ferreira (Portugal)

Panelist 3: Susanne Schneider (Germany)

Panelist 4: Annette Hand (UK)

Panelist 5: Nobutaka Hattori (Japan)

Membership Software Powered by YourMembership  ::  Legal